Stay updated on Durvalumab in Resectable Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab in Resectable Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe record history now shows an added revision entry v3.6.5 and the previous revision v3.6.4 was removed. This update reflects changes to the page's version history rather than to trial data or content.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page's revision metadata was updated from v3.6.3 to v3.6.4, indicating a new build of the page and updating the version shown in the history.SummaryDifference0.1%

- Check55 days agoChange DetectedThe study record history now shows a new revision entry, v3.6.3, superseding the previous v3.6.2. This indicates an update to the record's content or metadata.SummaryDifference0.1%

- Check64 days agoChange Detected- The page's revision label updated from v3.6.0 to v3.6.2 in the record history. This change indicates a newer version of the page's history UI and does not alter the study data, eligibility, status, or presented content.SummaryDifference0.1%

- Check78 days agoChange DetectedRecruitment status updated to 'no longer looking for participants', indicating that the study is not enrolling currently. The record now shows Revision: v3.6.0, replacing the previous Revision: v3.5.5.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page's footer revision tag was updated from v3.5.4 to v3.5.5. This reflects a new release of the page's content without altering study data or core functionality.SummaryDifference0.1%

Stay in the know with updates to Durvalumab in Resectable Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.